litlas
Log inCreate account

Dawn L. Hershman

Active 1994–2026

245
Papers
30,812
Citations
101
h-index
228
i10-index

Citations

Citations per year for Dawn L. Hershman1992: 1 citations1995: 3 citations1996: 1 citations1997: 4 citations1998: 3 citations1999: 1 citations2000: 2 citations2001: 5 citations2003: 6 citations2004: 7 citations2005: 15 citations2006: 28 citations2007: 51 citations2008: 68 citations2009: 90 citations2010: 110 citations2011: 110 citations2012: 144 citations2013: 186 citations2014: 215 citations2015: 248 citations2016: 222 citations2017: 262 citations2018: 210 citations2019: 902 citations2020: 980 citations2021: 1,078 citations2022: 950 citations2023: 684 citations2024: 1,303 citations2025: 563 citations2026: 13 citations1993–1994: no citations, so these years are not shown2002: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,753 citing papers, 34.3% of this breakdownChina: 835 citing papers, 7.6% of this breakdownUnited Kingdom: 643 citing papers, 5.9% of this breakdownCanada: 558 citing papers, 5.1% of this breakdownItaly: 542 citing papers, 4.9% of this breakdownGermany: 389 citing papers, 3.6% of this breakdownAustralia: 343 citing papers, 3.1% of this breakdownFrance: 326 citing papers, 3% of this breakdownSpain: 253 citing papers, 2.3% of this breakdownNetherlands: 245 citing papers, 2.2% of this breakdownJapan: 226 citing papers, 2.1% of this breakdownSwitzerland: 176 citing papers, 1.6% of this breakdown
0%34.3%Other 24.3%

Institutions

Fields

  • Medicine75.5%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Economics, Econometrics and Finance2.6%
  • Health Professions1.2%
  • Immunology and Microbiology0.9%
  • Psychology0.7%
  • Other4.3%

Topics

  • Cancer survivorship and care4.2%
  • Cancer Treatment and Pharmacology4%
  • Breast Cancer Treatment Studies3.2%
  • Global Cancer Incidence and Screening2.4%
  • Cancer Risks and Factors2.3%
  • Endometrial and Cervical Cancer Treatments2.2%
  • Other81.7%

Coauthors

All papers

Open in search
  1. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

    Authors: Larissa A. Korde, Mark R. Somerfield, Lisa A. Carey, Jennie R. Crews, Neelima Denduluri, E. Shelley Hwang, Seema A. Khan, Sibylle Loibl, Elizabeth A. Morris, Alejandra Perez, Meredith M. Regan, Patricia A. Spears, Preeti Sudheendra, W. Fraser Symmans, Rachel L. Yung, Brittany Harvey, Dawn L. Hershman - Journal of Clinical Oncology 2021 cited by 998

  2. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

    Authors: Charles L. Loprinzi, Christina Lacchetti, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan, Daniel L. Hertz, Mark R. Kelley, Antoinette Lavino, Maryam B. Lustberg, Judith A. Paice, Bryan P. Schneider, Elizabeth Smith, Mary Lou Smith, Thomas J. Smith, Nina D. Wagner‐Johnston, Dawn L. Hershman - Journal of Clinical Oncology 2020 cited by 1,057

  3. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation

    Authors: Joseph M. Unger, Riha Vaidya, Dawn L. Hershman, Lori M. Minasian, Mark E. Fleury - JNCI Journal of the National Cancer Institute 2018 cited by 560

  4. Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer

    Authors: Pamela J. Goodwin, Bingshu E. Chen, Karen A. Gelmon, Timothy J. Whelan, Marguerite Ennis, Julie Lemieux, Jennifer A. Ligibel, Dawn L. Hershman, Ingrid A. Mayer, Timothy J. Hobday, Judith M. Bliss, Priya Rastogi, Manuela Rabaglio, Som D. Mukherjee, John R. Mackey, Vandana G. Abramson, Conrad D. Oja, Robert Wesolowski, Alastair M. Thompson, Daniel Rea, Paul M. Stos, Lois E. Shepherd, Vuk Stambolic, Wendy R. Parulekar - JAMA 2022 cited by 223

  5. Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial

    Authors: Kevin Kalinsky, Melissa Accordino, Codruța Chiuzan, Prabhjot S. Mundi, Elizabeth Sakach, Claire Sathe, Heejoon Ahn, Meghna S. Trivedi, Yelena Novik, Amy Tiersten, George Raptis, Lea Baer, Sun Young Oh, Amelia Zelnak, Kari B. Wisinski, Eleni Andreopoulou, William J. Gradishar, Erica Stringer-Reasor, Sonya Reid, Anne O’Dea, Ruth O’Regan, Katherine D. Crew, Dawn L. Hershman - Journal of Clinical Oncology 2023 cited by 191

  6. Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

    Authors: Joseph M. Unger, Riha Vaidya, Kathy S. Albain, Michael LeBlanc, Lori M. Minasian, Carolyn C. Gotay, N. Lynn Henry, Michael J. Fisch, Shing M. Lee, Charles D. Blanke, Dawn L. Hershman - Journal of Clinical Oncology 2022 cited by 317

  7. “When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials

    Authors: Joseph M. Unger, Dawn L. Hershman, Cathee Till, Lori M. Minasian, Raymond U. Osarogiagbon, Mark E. Fleury, Riha Vaidya - JNCI Journal of the National Cancer Institute 2020 cited by 248

  8. Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline

    Authors: Judith A. Paice, Kari Bohlke, Debra L. Barton, David S. Craig, Areej El‐Jawahri, Dawn L. Hershman, Lynn R Kong, Geana Paula Kurita, Thomas W. LeBlanc, Sebastiano Mercadante, Kristina L. M. Novick, Ramy Sedhom, Carole Seigel, Joanna Stimmel, Éduardo Bruera - Journal of Clinical Oncology 2022 cited by 259

  9. Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline

    Authors: Gary H. Lyman, Heather Greenlee, Kari Bohlke, Ting Bao, Angela DeMichele, Gary Deng, Judith M. Fouladbakhsh, Brigitte Gil, Dawn L. Hershman, Sami Mansfield, Dawn M. Mussallem, Karen M. Mustian, Erin Price, Susan Rafte, Lorenzo Cohen - Journal of Clinical Oncology 2018 cited by 415

  10. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

    Authors: Dawn L. Hershman, Theresa Shao, Lawrence H. Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn L. Kwan, Scarlett Lin Gomez, Alfred I. Neugut - Breast Cancer Research and Treatment 2010 cited by 880

  11. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

    Authors: Dawn L. Hershman, Christina Lacchetti, Robert H. Dworkin, Elizabeth Smith, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan, Patrick G. Gavin, Antoinette Lavino, Maryam B. Lustberg, Judith A. Paice, Bryan P. Schneider, Mary Lou Smith, Tom Smith, Shelby A. Terstriep, Nina D. Wagner‐Johnston, Kate Bak, Charles L. Loprinzi - Journal of Clinical Oncology 2014 cited by 1,220

  12. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study

    Authors: Heather Greenlee, Carlos Iribarren, Jamal S. Rana, Richard K. Cheng, Mai N. Nguyen‐Huynh, Eileen Rillamas‐Sun, Zaixing Shi, Cecile A. Laurent, Valerie S. Lee, Janise M. Roh, Margarita Santiago‐Torres, Hanjie Shen, Dawn L. Hershman, Lawrence H. Kushi, Romain Neugebauer, Marilyn L. Kwan - Journal of Clinical Oncology 2022 cited by 158

  13. Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)

    Authors: Christine B. Ambrosone, Gary Zirpoli, Alan D. Hutson, William McCann, Susan E. McCann, William E. Barlow, Kara M. Kelly, Rikki Cannioto, Lara E. Sucheston‐Campbell, Dawn L. Hershman, Joseph M. Unger, Halle C. F. Moore, James A. Stewart, Claudine Isaacs, Timothy J. Hobday, Muhammad Salim, Gabriel N. Hortobágyi, Julie R. Gralow, G. Thomas Budd, Kathy S. Albain - Journal of Clinical Oncology 2019 cited by 234

  14. Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival

    Authors: Rikki Cannioto, Alan D. Hutson, Shruti Dighe, William McCann, Susan E. McCann, Gary Zirpoli, William E. Barlow, Kara M. Kelly, Carol A DeNysschen, Dawn L. Hershman, Joseph M. Unger, Halle C. F. Moore, James A. Stewart, Claudine Isaacs, Timothy J. Hobday, Muhammad Salim, Gabriel N. Hortobágyi, Julie R. Gralow, Kathy S. Albain, G. Thomas Budd, Christine B. Ambrosone - JNCI Journal of the National Cancer Institute 2020 cited by 187

  15. National Estimates of Gender-Affirming Surgery in the US

    Authors: Jason D. Wright, Ling Chen, Yukio Suzuki, Koji Matsuo, Dawn L. Hershman - JAMA Network Open 2023 cited by 166

  16. Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study

    Authors: Tara Sanft, Maura Harrigan, Courtney McGowan, Brenda Cartmel, Michelle Zupa, Fangyong Li, Leah M. Ferrucci, Leah Puklin, Anlan Cao, Thai Hien Nguyen, Marian L. Neuhouser, Dawn L. Hershman, Karen Basen‐Engquist, Beth A. Jones, Tish Knobf, Anees B. Chagpar, Andrea Silber, Anna Tanasijevic, Jennifer A. Ligibel, Melinda L. Irwin - Journal of Clinical Oncology 2023 cited by 86

  17. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer

    Authors: Dawn L. Hershman, Joseph M. Unger, Heather Greenlee, Jillian L. Capodice, Danika L. Lew, Amy K. Darke, Alice Tam Kengla, Marianne K. Melnik, Carla Walker Jorgensen, William Kreisle, Lori M. Minasian, Michael Fisch, N. Lynn Henry, Katherine D. Crew - JAMA 2018 cited by 287

  18. Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

    Authors: Tizita Zeleke, Qingfei Pan, Codruța Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J. Alvarez, Erin Honan, Min Yang, Pei Ling Chia, Partha Mukhopadhyay, Sean Kelly, Ruby Wu, Kathleen Fenn, Meghna S. Trivedi, Melissa Accordino, Katherine D. Crew, Dawn L. Hershman, Matthew Maurer, Simon Jones, Anthony A. High, Junmin Peng, Andrea Califano, Kevin Kalinsky, Jiyang Yu, Jose Silva - Nature Cancer 2022 cited by 77

  19. Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

    Authors: Dawn L. Hershman, Lawrence H. Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum, Wei‐Yann Tsai, Louis Fehrenbacher, Scarlett Lin Gomez, Sunita Miles, Alfred I. Neugut - Journal of Clinical Oncology 2010 cited by 829

  20. Randomized Exercise Trial of Aromatase Inhibitor–Induced Arthralgia in Breast Cancer Survivors

    Authors: Melinda L. Irwin, Brenda Cartmel, Cary P. Gross, Elizabeth Ercolano, Fangyong Li, Xiaopan Yao, Martha Fiellin, Scott Capozza, Marianna Rothbard, Zhou Yang, Maura Harrigan, Tara Sanft, Kathryn H. Schmitz, Tuhina Neogi, Dawn L. Hershman, Jennifer A. Ligibel - Journal of Clinical Oncology 2014 cited by 322

  21. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines

    Authors: Jason D. Wright, Koji Matsuo, Yongmei Huang, Ana I. Tergas, June Y. Hou, Fady Khoury‐Collado, Caryn M. St. Clair, Cande V. Ananth, Alfred I. Neugut, Dawn L. Hershman - Obstetrics and Gynecology 2019 cited by 294

  22. Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials

    Authors: Joseph M. Unger, Anna Moseley, Banu Symington, Mariana Chávez‐MacGregor, Scott D. Ramsey, Dawn L. Hershman - JAMA Network Open 2018 cited by 206

  23. Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials

    Authors: Joseph M. Unger, Anna Moseley, Christabel K. Cheung, Raymond U. Osarogiagbon, Banu Symington, Scott D. Ramsey, Dawn L. Hershman - Journal of Clinical Oncology 2021 cited by 145

  24. American Society of Clinical Oncology Position Statement on Obesity and Cancer

    Authors: Jennifer A. Ligibel, Catherine M. Alfano, Kerry S. Courneya, Wendy Demark‐Wahnefried, Robert A. Burger, Rowan T. Chlebowski, Carol J. Fabian, Ayca Gucalp, Dawn L. Hershman, Melissa M. Hudson, Lee W. Jones, Madhuri Kakarala, Kirsten K. Ness, Janette K. Merrill, Dana S. Wollins, Clifford A. Hudis - Journal of Clinical Oncology 2014 cited by 524